1. What is the role of the Appellate Board under The Drug Regulatory Authority of Pakistan Act, 2012?
2. How often must records of quarterly production and disposal of a drug be supplied to the Chairman of the Registration Board?
3. What is the consequence of violating the conditions of a license to import drugs or the provisions of the Act?
4. The Authority shall levy and collect fees for its functions at rates determined by:
5. Under what conditions are drug advertisements to the general public generally permitted?
6. Who is responsible for maintaining records of quarterly production and disposal of a drug?
7. What is the condition under which printing of labeling for therapeutic goods is allowed under Schedule-II?
8. What must be included in the labelling and promotion of a registered drug?
9. The Authority may open its accounts with:
10. Which of the following offenses punishable under Schedule-III is non-cognizable?
11. How many members does the Policy Board consist of?
12. What is the purpose of the criteria regarding medical representatives?
13. What does the term "batch number (or lot number)" refer to?
14. Which power of the Inspector requires specific authorization by the Government?
15. What is the Appellate Board's authority to call for the record of a case for review?
16. What is the punishment for violating any prohibitions specified in Schedule-II of the DRAP Act?
17. Which of the following actions related to therapeutic goods is PROHIBITED under Schedule-II?
18. What is the primary focus of basic research in the context of the Drugs (Research) Rules?
19. What are "Medical Devices" under Schedule-I?
20. What is the primary function of the Federal Drug Laboratory as stated in the rules?
21. Under what conditions can the aid from the research fund be withdrawn and a clinical trial terminated?
22. Who is considered an "investigator" under the Drugs (Research) Rules?
23. Which authority may authorize a Federal Inspector to disclose information acquired during official duties?
24. What is the duration of a license to import drugs, unless suspended or canceled?
25. For drugs other than those falling under specific categories, whose approval is required for the specifications?
26. Who may physically inspect an imported consignment, draw samples, and order the importer not to sell or dispose of the drug for a specific period?
27. What is the purpose of the Drugs (Research) Rules, 1978?
28. What is the purpose of Form 10 in the export of drugs?
29. What information should be included in the written contract between the contract giver and contract acceptor for contract manufacture?
30. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
31. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
32. In what type of premises should the manufacturing of drugs by way of basic or semi-basic manufacture take place?
33. The Drugs Act, 1976 extends to which of the following areas?
34. Which power of the Inspector requires specific authorization by the Government?
35. Who serves as the ex-officio Chairman of the Appellate Board?
36. Which of the following offenses punishable under Schedule-III is non-cognizable?
37. Which of the following is NOT considered as "Therapeutic goods" under the Act?
38. What are "Medicated Cosmetics" under Schedule-I?
39. What is the purpose of an "airlock" in pharmaceutical manufacturing?
40. What is the maximum duration of a licence issued under Drugs Licensing, Registering & Advertising rules 1976?
41. What stage of investigation on human beings involves determining safety, effectiveness, and common side effects of a drug?
42. What labeling requirements apply to drugs manufactured for experimental purposes?
43. What action should the Authority take in response to objections raised by the Auditor-General?
44. What does an Inspector require from a person during a search or seizure under Schedule-V?
45. What is the purpose of Schedule-III of the DRAP Act?
46. What are the conditions that the Central Licensing Board must ensure are complied with before granting or renewing a licence to manufacture drugs by way of basic or semi-basic manufacture?
47. What is the penalty for giving a false warranty in respect of any therapeutic good or applying a warranty given for another therapeutic good?
48. In what circumstances shall a drug not be deemed misbranded or adulterated?
49. What is the maximum time limit for submieng an appeal to the Appellate Board after receiving a decision?
50. What is the punishment for a person who exports, imports, manufactures for sale, or sells any spurious therapeutic good or any unregistered therapeutic good?
51. What is the fee for submitting an appeal to the Appellate Board, as mentioned in the rules?
52. What type of containers are ophthalmic solutions and suspensions required to be contained in?
53. What is the short title of the rules that govern the Drugs Appellate Board?
54. What is the purpose of the Committee on Drugs Evaluation?
55. What is the purpose of The Drug Regulatory Authority of Pakistan Act, 2012?
56. What is the purpose of the license to manufacture drugs for experimental purposes?
57. What is the maximum period for which an Inspector can forbid a person in charge of premises from removing or dispensing therapeutic goods?
58. What should an Inspector do if he finds that the therapeutic good does not contravene any provisions of the Act?
59. What is the primary purpose of the Committee of Experts on Drug Research?
60. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
61. In case of an appeal against the decision of the Registration Board rejecting an application for registration of a drug, what statement is required to be submitted?
62. According to the Drugs (Specifications) Rules, 1978, what is the requirement for ophthalmic ointments?
63. In what situations can a drug or substance be advertised to the medical, pharmaceutical, and allied professions without referring to the Federal Government?
64. What is the maximum allowable retailer's discount for drugs?
65. What is the main duty of a Federal Inspector?
66. Who shall not be liable for a contravention of Section 23 of the Drugs Act 1976?
67. What is the purpose of Schedule-III of the DRAP Act?
68. What is the penalty for selling a drug in the finished form over and above the maximum retail price fixed by the Federal Government?
69. Who qualifies as a Federal Inspector according to these rules?
70. What is the penalty for a person who fails to provide information requested by the Authority?
71. When does an Inspector need to divide a sample into three portoons instead of four?
72. In case of inconsistency between the provisions of the DRAP Act and any other law, what takes precedence?
73. What are "Medicated Cosmetics" under Schedule-I?
74. What is the duration of a license to export drugs?
75. What is the tenure of the CEO's appointment, and how many times can it be extended?
76. What does the term "Advertise" mean under Schedule-II?
77. Within what time frame should the Authority submit its annual report to the Federal Government?
78. What is the penalty for a person who fails to provide information requested by the Authority?
79. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
80. What degree qualifications are required for the competent technical staff involved in the manufacture of drugs by way of basic or semi-basic manufacture?
81. What is the role of the Quality Control Department in the manufacturing process?
82. Which of the following is NOT included in the definition of "Biologicals" under Schedule-I?
83. What is the purpose of the Drug Regulatory Authority of Pakistan Fund?
84. What condition must be met for a drug or substance to be advertised through press without reference to the Federal Government?
85. What is the meaning of "Reference Biotherapeutic Product (RBP)" under ScheduleI?
86. What is the purpose of an "airlock" in pharmaceutical manufacturing?
87. What is the purpose of the Central Research Fund mentioned in the Drugs Licensing, Registering & Advertising Rules 1976?
88. What substances are NOT included in the definition of "Drug" under Schedule-I?
89. In which circumstances may the Registration Board register a drug on its own motion?
90. What ethical criteria should be followed for medical drug promotion?
91. Who can revoke an order passed under Section 32 of the DRAP Act, 2012?
92. Which Division is responsible for the evaluation, assessment, and registration of pharmaceutical drugs for human beings and animals?
93. Within what time frame should the Authority submit its annual report to the Federal Government?
94. Under what conditions is contract manufacture permissible?
95. Where should one portion of a sample taken by an Inspector be sent for test and analysis?
96. What is the penalty for a subsequent offense under Clause (1) of Schedule-III?
97. Under what condition can finished drugs be imported?
98. What is the role of the Quality Control Department in the manufacturing process?
99. Who has the authority to make rules for carrying out the purposes of the DRAP Act 2012?
100. What is the age requirement for the Chief Executive Officer (CEO) of the Authority?